Research ExplorerPublicationsConcomitant minimally invasive HVAD and transapical aortic v...

Concomitant minimally invasive HVAD and transapical aortic valve implantation

Standard

Concomitant minimally invasive HVAD and transapical aortic valve implantation. / Schaefer, Andreas; Treede, Hendrik; Bernhardt, Alexander; Wagner, Florian M; Reichenspurner, Hermann; Deuse, Tobias.

In: ASAIO J, Vol. 61, No. 2, 26.11.2014, p. 209-912.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schaefer, A, Treede, H, Bernhardt, A, Wagner, FM, Reichenspurner, H & Deuse, T 2014, 'Concomitant minimally invasive HVAD and transapical aortic valve implantation', ASAIO J, vol. 61, no. 2, pp. 209-912. https://doi.org/10.1097/MAT.0000000000000177

APA

Schaefer, A., Treede, H., Bernhardt, A., Wagner, F. M., Reichenspurner, H., & Deuse, T. (2014). Concomitant minimally invasive HVAD and transapical aortic valve implantation. ASAIO J, 61(2), 209-912. https://doi.org/10.1097/MAT.0000000000000177

Vancouver

Schaefer A, Treede H, Bernhardt A, Wagner FM, Reichenspurner H, Deuse T. Concomitant minimally invasive HVAD and transapical aortic valve implantation. ASAIO J. 2014 Nov 26;61(2):209-912. https://doi.org/10.1097/MAT.0000000000000177

Bibtex

@article{bc96953c949546ac98b1f84758633b41,
title = "Concomitant minimally invasive HVAD and transapical aortic valve implantation",
abstract = "Minimally invasive left ventricular assist device (LVAD) implantation with the HeartWare VAD (HVAD) has been reported lately as an alternative approach to median sternotomy due to its favorable results regarding sternal wound complications, mediastinitis, postoperative bleeding, and right ventricular failure (RVF). Relevant aortic regurgitation is a cardiac comorbidity that requires surgical repair at the time of LVAD implantation to reduce recirculation and ensure adequate forward flow. We herein report on a patient with severely reduced left ventricular function due to ischemic cardiomyopathy, moderate aortic regurgitation, and a reduced right ventricular function. We performed minimally invasive HVAD implantation with concomitant transapical transcatheter aortic valve replacement. We believe this hybrid procedure could potentially reduce the risk for post-LVAD RVF because it preserves the pericardial geometry and obviates the need for cardioplegic arrest. ",
keywords = "Aged, Aortic Valve Insufficiency/complications, Heart Failure/complications, Heart-Assist Devices/adverse effects, Humans, Male, Minimally Invasive Surgical Procedures/methods, Transcatheter Aortic Valve Replacement/methods",
author = "Andreas Schaefer and Hendrik Treede and Alexander Bernhardt and Wagner, {Florian M} and Hermann Reichenspurner and Tobias Deuse",
year = "2014",
month = nov,
day = "26",
doi = "10.1097/MAT.0000000000000177",
language = "English",
volume = "61",
pages = "209--912",
journal = "ASAIO J",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Concomitant minimally invasive HVAD and transapical aortic valve implantation

AU - Schaefer, Andreas

AU - Treede, Hendrik

AU - Bernhardt, Alexander

AU - Wagner, Florian M

AU - Reichenspurner, Hermann

AU - Deuse, Tobias

PY - 2014/11/26

Y1 - 2014/11/26

N2 - Minimally invasive left ventricular assist device (LVAD) implantation with the HeartWare VAD (HVAD) has been reported lately as an alternative approach to median sternotomy due to its favorable results regarding sternal wound complications, mediastinitis, postoperative bleeding, and right ventricular failure (RVF). Relevant aortic regurgitation is a cardiac comorbidity that requires surgical repair at the time of LVAD implantation to reduce recirculation and ensure adequate forward flow. We herein report on a patient with severely reduced left ventricular function due to ischemic cardiomyopathy, moderate aortic regurgitation, and a reduced right ventricular function. We performed minimally invasive HVAD implantation with concomitant transapical transcatheter aortic valve replacement. We believe this hybrid procedure could potentially reduce the risk for post-LVAD RVF because it preserves the pericardial geometry and obviates the need for cardioplegic arrest.

AB - Minimally invasive left ventricular assist device (LVAD) implantation with the HeartWare VAD (HVAD) has been reported lately as an alternative approach to median sternotomy due to its favorable results regarding sternal wound complications, mediastinitis, postoperative bleeding, and right ventricular failure (RVF). Relevant aortic regurgitation is a cardiac comorbidity that requires surgical repair at the time of LVAD implantation to reduce recirculation and ensure adequate forward flow. We herein report on a patient with severely reduced left ventricular function due to ischemic cardiomyopathy, moderate aortic regurgitation, and a reduced right ventricular function. We performed minimally invasive HVAD implantation with concomitant transapical transcatheter aortic valve replacement. We believe this hybrid procedure could potentially reduce the risk for post-LVAD RVF because it preserves the pericardial geometry and obviates the need for cardioplegic arrest.

KW - Aged

KW - Aortic Valve Insufficiency/complications

KW - Heart Failure/complications

KW - Heart-Assist Devices/adverse effects

KW - Humans

KW - Male

KW - Minimally Invasive Surgical Procedures/methods

KW - Transcatheter Aortic Valve Replacement/methods

U2 - 10.1097/MAT.0000000000000177

DO - 10.1097/MAT.0000000000000177

M3 - SCORING: Journal article

C2 - 25423118

VL - 61

SP - 209

EP - 912

JO - ASAIO J

JF - ASAIO J

SN - 1058-2916

IS - 2

ER -